**RFK Jr. remains firmly positioned as HHS Secretary with no verified signals of imminent departure.** Confirmed by the Senate in February 2025, he continues to lead departmental reorganizations, including recent senior leadership adjustments announced in September 2026 that consolidate operations under new counselors while advancing MAHA priorities such as dietary policy and agency streamlining. President Trump has repeatedly expressed support, hosting Kennedy alongside other officials and aligning on health initiatives ahead of the midterms. Kennedy has publicly affirmed his focus on the role rather than future campaigns, and administration actions show him directing vaccine policy shifts, staffing expansions for political appointees, and budget execution for fiscal 2026. These developments reflect sustained alignment with White House objectives, underpinning trader consensus that he will serve through year-end.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated$24,303 Vol.
$24,303 Vol.
$24,303 Vol.
$24,303 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Market Opened: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...**RFK Jr. remains firmly positioned as HHS Secretary with no verified signals of imminent departure.** Confirmed by the Senate in February 2025, he continues to lead departmental reorganizations, including recent senior leadership adjustments announced in September 2026 that consolidate operations under new counselors while advancing MAHA priorities such as dietary policy and agency streamlining. President Trump has repeatedly expressed support, hosting Kennedy alongside other officials and aligning on health initiatives ahead of the midterms. Kennedy has publicly affirmed his focus on the role rather than future campaigns, and administration actions show him directing vaccine policy shifts, staffing expansions for political appointees, and budget execution for fiscal 2026. These developments reflect sustained alignment with White House objectives, underpinning trader consensus that he will serve through year-end.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions